EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Hypokalaemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation

Anthony Frosio iD, Procolo Marchese iD, Giorgia Bertoli iD, David Molla iD, Martina Arici iD, Chiara Bartolucci iD, Chiara Piantoni iD, Giulia Guidi, Claudia Bazzini, Patrizia Benzoni iD, Raffaella Milanesi iD, Antonio Fortunato iD und 9 weitere

Europace · 03.02.2026 · 28 (2)

DOI: 10.1093/europace/euaf160 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Europace, online erschienen am 31.07.2025. Verfasst von Anthony Frosio und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, MiLab and "Centro Interuniversitario di Medicina Molecolare e Biofisica Applicata", Università degli Studi di Milano, Mila…. Hauptthemen laut MEDLINE: Brugada Syndrome, NAV1.5 Voltage-Gated Sodium Channel, Hypokalemia, Bradycardia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union - NextGenerationEU, Italian Ministry of University and Research, HEAL ITALIA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Loss-of-function (LOF) mutations of the cardiac Na+ channel (SCN5A) are causatively associated with the Brugada Syndrome (BrS). However, the onset of Ventricular Fibrillation (VF) is a rare event, and critical factors favouring the pathological phenotype remain often elusive. This study explores how concomitant triggering conditions may impact on VF onset in a symptomatic proband carrying the S805L/SCN5A BrS mutation. Methods and results Clinical, in-vitro, numerical, and structural analyses were performed. A 67-year-old male was resuscitated after cardiac arrest, and clinical analysis upon hospitalisation revealed severe hypokalaemia (2.5 mEq/L). The ECG showed a coved type-I BrS pattern and the SCN5A mutation (S805L) was identified. Patch-clamp studies carried out in a heterologous expression system (HEK293 cells) revealed that WT/S805L channels exhibit two different phenotypes (normal and LOF); the main parameter controlling this distribution is the cell membrane potential. A protected/normal behaviour was observed at −80 mV; conversely, LOF occurred at more negative potentials (−100/−120 mV). Further analyses in isolated outflow tract ventricular cardiomyocytes showed that hypokalaemia (and bradycardia) induced diastolic potential hyperpolarisation, thus favouring the Na+ current LOF. Computational and molecular modelling confirmed our findings and revealed the structural determinant of this alteration.

Conclusion

WT/S805L Na+ channels exhibit either a LOF or a wild-type-like behaviour depending on the membrane potential. Since hypokalaemia and slow pacing rate induce cell hyperpolarisation and the associated LOF, they represent concurrent elements creating the scenario responsible for the VF and cardiac arrest. These results may represent an interpretative paradigm applicable to other BrS mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brugada SyndromeNAV1.5 Voltage-Gated Sodium ChannelHypokalemiaBradycardiaLoss of Function MutationVentricular FibrillationHumansMaleAgedPhenotypeAction PotentialsHEK293 CellsGenetic Predisposition to DiseaseElectrocardiographyHeart RatePatch-Clamp TechniquesMyocytes, Cardiac

Stichwörter der Autor:innen

ArrhythmiasBrugada syndromeHypokalaemiaSCN5A

Substanzen

NAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, human

Autor:innen und Institutionen

  • Department of Biosciences, MiLab and "Centro Interuniversitario di Medicina Molecolare e Biofisica Applicata", Università degli Studi di Milano, Milano 20133, Italy.
  • Cardiology Unit, AST Ascoli Piceno, Ascoli Piceno, Italy.
  • Department of Biotechnology and Biosciences, Università degli Studi di Milano Bicocca, Milan, Italy.
  • Department of Electrical, Electronic and Information Engineering Guglielmo Marconi, University of Bologna, Cesena, Italy.
  • U.O.C. Clinical Pathology Unit, AST Ascoli Piceno, Ascoli Piceno, Italy.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

ORCID-Profile: Anthony Frosio, Procolo Marchese, Giorgia Bertoli, David Molla, Martina Arici, Chiara Bartolucci, Chiara Piantoni, Patrizia Benzoni, Raffaella Milanesi, Antonio Fortunato, Yi Wang, Riccardo Cappato, Marco Nardini, Stefano Severi, Annalisa Bucchi, Marcella Rocchetti, Mirko Baruscotti

Förderung

  • European Union - NextGenerationEU
  • Italian Ministry of University and Research
  • HEAL ITALIA
  • University of Milano-Bicocca

Zitieren

APA

Frosio, A., Marchese, P., Bertoli, G., Molla, D., Arici, M., Bartolucci, C., Piantoni, C., Guidi, G., Bazzini, C., Benzoni, P., Milanesi, R., Fortunato, A., Grossi, P., Pianese, L., Wang, Y., Cappato, R., Nardini, M., Severi, S., Bucchi, A., …, & Baruscotti, M. (2026). Hypokalaemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation. Europace, 28(2). https://doi.org/10.1093/europace/euaf160

Vancouver

Frosio A, Marchese P, Bertoli G, Molla D, Arici M, Bartolucci C, et al. Hypokalaemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation. Europace. 2026;28(2). doi:10.1093/europace/euaf160

BibTeX
@article{Frosio2026,
  author = {Frosio, Anthony and Marchese, Procolo and Bertoli, Giorgia and Molla, David and Arici, Martina and Bartolucci, Chiara and Piantoni, Chiara and Guidi, Giulia and Bazzini, Claudia and Benzoni, Patrizia and Milanesi, Raffaella and Fortunato, Antonio and Grossi, Pierfrancesco and Pianese, Luigi and Wang, Yi and Cappato, Riccardo and Nardini, Marco and Severi, Stefano and Bucchi, Annalisa and Rocchetti, Marcella and Baruscotti, Mirko},
  title = {Hypokalaemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation},
  journal = {Europace},
  year = {2026},
  volume = {28},
  number = {2},
  doi = {10.1093/europace/euaf160}
}
Kostenlos starten →